Stacy Hoffmann

Stacy Hoffmann is the Executive Director of Commercial Effectiveness at Zevra Therapeutics, a position held since 2023. Previously, they served as Senior Director of Commercial Operations and Excellence at Fennec Pharmaceuticals Inc from 2022 to 2023 and held various roles at Lundbeck between 2012 and 2018, including Sr Manager Marketing Operations and Associate Director of Marketing Operations. Hoffmann also worked at Orphazyme as Head of Field Training and Market Operations Effectiveness from 2020 to 2022 and at AveXis, Inc. as Director of Training and Development from 2018 to 2020. Their career commenced at Takeda Pharmaceuticals, where they were involved in Marketing Operations from 2000 to 2010. Hoffmann is currently pursuing a Bachelor of Science degree at Elmhurst College.